SII stopped manufacturing Covishield since December 2021, says 'disclosed side effects details in packaging insert'
Wednesday, 8 May 2024
SII stopped Covishield extra doses due to lawsuit, disclosed rare Thrombosis. Advocates govt collaboration. AstraZeneca withdraws Vaxzevria marketing authorisations globally. European Medicines Agency confirms Vaxzevria discontinuation in EU.
|
||||
💡 newsR Knowledge: Other News MentionsYou Might Like |
||||
